Evidence map›Paper›PMID 33321160›Full record

ArticleDiabetes research and clinical practice2021

Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey.

Mohamed Hassanein, Reem M Alamoudi, Majd-Aldeen Kallash, Naji J Aljohani, Eman M Alfadhli, Lobna El Tony, Ghofran S Khogeer, Abdulaziz F Alfadhly, Ahmed ElMamoon Khater, Muhammad Yakoob Ahmedani and 7 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Improving knowledge on the management of diabetes mellitus during Ramadan.Journal of Taibah University Medical Sciences · 2025
    Article
  5. Article
  6. Review
  7. Managing obesity in adults with type 1 diabetes.Diabetes research and clinical practice · 2025
    Review
  8. Observational
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 5 countries.

Mohamed HassaneinDepartment of Endocrinology and Diabetes, Dubai Hospital, Dubai, United Arab Emirates. Electronic address: mhassanein148@hotmail.com.
Reem M AlamoudiDepartment of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Majd-Aldeen KallashKing Fahad Medical City Riyadh, Saudi Arabia.
Naji J AljohaniDepartment of Obesity, Endocrine and Metabolic Center, King Abdulaziz bin Saud University for Health Sciences, Saudi Arabia.
Eman M AlfadhliDepartment of Medicine, Medical College, Taibah University Madinah, Saudi Arabia.
Lobna El TonyDepartment of Diabetes and Endocrine Centre, Assiut University, Egypt.
Ghofran S KhogeerKing Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
Abdulaziz F AlfadhlyDepartment of Family Medicine, Prince Mansour Military Hospital, Taif City, Saudi Arabia.
Ahmed ElMamoon KhaterStudies & Research & Data analysis Department, Dubai Health Authority, Dubai, United Arab Emirates.
Muhammad Yakoob AhmedaniDepartment of Medicine, Baqai Institute of Diabetology & Endocrinology, Baqai Medical University, Karachi, Pakistan.
Mehmet Akif BuyukbeseDepartment of Internal Medicine, Medistate Kavacik Hospital, Istanbul, Turkey.
Inass ShaltoutDepartment of Internal Medicine and Diabetes, Faculty of Medicine, Cairo University, Cairo, Egypt.
Jamal BelkhadirMoroccan League for the Fight Against Diabetes, IDF Middle East and North Africa, Morocco.
Khadija HafidhDiabetes Unit, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates.
Tahseen A ChowdhuryDepartment of Diabetes and Metabolism, The Royal London Hospital, Whitechapel, London, United Kingdom.
Zanariah HusseinDepartment of Internal Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
Nancy Samir ElbarbaryDepartment of Pediatrics, Ain Shams University, Cairo, Egypt.
Dubai Health Authority · AEKing Saud bin Abdulaziz University for Health Sciences · SAAin Shams University · EGAssiut University · EGBaqai Medical University · PKCairo University · EGDubai Hospital · AEKing Abdulaziz Medical City · SAKing Fahd Medical City · SARoyal London Hospital · GBTaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe DaR Global survey was conducted to determine the impact of the COVID-19 pandemic on the intentions to fast and the outcomes of fasting in <18 years versus ≥18 years age groups with type 1 diabetes mellitus (T1DM).

methodsMuslim people with T1DM were surveyed in 13 countries between June and August 2020, shortly after the end of Ramadan (23rd April-23rd May 2020) using a simple questionnaire.

results71.1% of muslims with T1DM fasted during Ramadan. Concerns about COVID-19 were higher in individuals ≥18 years (p = 0.002). The number of participants who decided not to fast plus those who received Ramadan-focused education were significantly higher in the ≥18-year group (p < 0.05). Hypoglycemia (60.7%) as well as hyperglycemia (44.8%) was major complications of fasting during Ramadan in both groups irrespective of age.

conclusionCOVID-19 pandemic had minor impact on the decision to fast Ramadan in T1DM cohort. This was higher in the age group of ≥18 years compared to those <18 years group. Only regional differences were noted for fasting attitude and behavior among T1DM groups. This survey highlights the need for Ramadan focused diabetes education to improve glucose control and prevent complications during fasting.

Indexed as

IslamPandemicsSARS-CoV-2AdolescentAdultCohort StudiesCOVID-19Diabetes Mellitus, Type 1FastingFemaleGlobal HealthHealth EducationHumansHypoglycemic AgentsMaleMiddle AgedHypoglycemic AgentsCoronavirusCOVID-19RamadanSurveyType 1 diabetes

Identifiers

PMID33321160
PMCPMC7836519
OpenAlexW3112637164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.